Latus Bio is a biotechnology company focused on developing gene therapy candidates using adeno-associated virus (AAV) vectors to target diseases of the central nervous system and the periphery. The company engineers novel AAV capsid variants and optimizes delivery methods to improve the precision of gene transfer to specific tissues and cell types.